Supaglutide
A Study of the Efficacy and Safety of Supaglutide in Healthy Participants
Shanghai Yinnuo Pharmaceutical Technology Co. · Phase 1 · Completed · Enrollment 48
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| 0.15mg Supaglutide or placebo | T2D only | 0.15mg | n/r | n/r | n/r |
| 0.375mg Supaglutide or placebo | T2D only | 0.375mg | n/r | n/r | n/r |
| 0.75mg Supaglutide or placebo | T2D only | 0.75mg | n/r | n/r | n/r |
| 1.5mg Supaglutide or placebo | T2D only | 1.5mg | n/r | n/r | n/r |
| 3.0mg Supaglutide or placebo | T2D only | 3.0mg | n/r | n/r | n/r |